141 related articles for article (PubMed ID: 1357858)
1. Effects of antihistamines on cutaneous reactions and influx of eosinophils after local injection of PAF, kallikrein, compound 48/80 and histamine in patients with chronic urticaria and healthy subjects.
Juhlin L; Pihl-Lundin I
Acta Derm Venereol; 1992; 72(3):197-200. PubMed ID: 1357858
[TBL] [Abstract][Full Text] [Related]
2. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
Sansom JE; Brooks J; Burton JL; Archer CB
Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
[TBL] [Abstract][Full Text] [Related]
3. Effect of cetirizine on cutaneous reactions to PAF, kallikrein and serum in patients with chronic urticaria.
Juhlin L; Rihoux JP
Acta Derm Venereol; 1990; 70(2):151-3. PubMed ID: 1969202
[TBL] [Abstract][Full Text] [Related]
4. Aberrant cutaneous weal and flare responses in chronic urticaria.
Shall L; Saihan EM
Acta Derm Venereol; 1992 Nov; 72(6):451-3. PubMed ID: 1362842
[TBL] [Abstract][Full Text] [Related]
5. Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses.
Bayramgürler D; Bilen N; Apaydýn R; Altintaş L; Sal G; Dökmeci S; Utkan T
Clin Exp Dermatol; 1999 Sep; 24(5):407-11. PubMed ID: 10564333
[TBL] [Abstract][Full Text] [Related]
6. Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers.
Boyle J; Ridout F; Meadows R; Johnsen S; Hindmarch I
Curr Med Res Opin; 2005 Sep; 21(9):1495-503. PubMed ID: 16197669
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation.
Krause K; Giménez-Arnau A; Martinez-Escala E; Farré-Albadalejo M; Abajian M; Church MK; Maurer M
Allergy; 2013 Feb; 68(2):256-8. PubMed ID: 23320562
[TBL] [Abstract][Full Text] [Related]
8. Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity.
Grattan CE; Dawn G; Gibbs S; Francis DM
Clin Exp Allergy; 2003 Mar; 33(3):337-41. PubMed ID: 12614448
[TBL] [Abstract][Full Text] [Related]
9. The role of histamine in the acute inflammatory responses to intradermal platelet activating factor.
Sciberras DG; Jordan S; Gill D; Baber NS; James I
Br J Clin Pharmacol; 1991 Jul; 32(1):85-90. PubMed ID: 1679658
[TBL] [Abstract][Full Text] [Related]
10. [Comparative activity of antihistamines on area under dose-response curve from histamine-induced wheal and flare responses in human skin].
Wang RQ; Zhang HY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):634-8. PubMed ID: 15663222
[TBL] [Abstract][Full Text] [Related]
11. Late-phase cutaneous reactions to platelet activating factor and kallikrein in urticaria.
Juhlin L
Clin Exp Allergy; 1990 Nov; 20 Suppl 4():9-10. PubMed ID: 1980857
[No Abstract] [Full Text] [Related]
12. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
13. Comparison of weal and flare responses to platelet activating factor (PAF) and histamine, and the ultrastructural effects of PAF in the skin of atopic and normal subjects.
Jenks PJ; Kavanagh GM; Brooks J; Bradfield JW; Archer CB
Clin Exp Dermatol; 1999 Mar; 24(2):112-7. PubMed ID: 10233666
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor induces histamine release from human skin mast cells in vivo, which is reduced by local nerve blockade.
Petersen LJ; Church MK; Skov PS
J Allergy Clin Immunol; 1997 May; 99(5):640-7. PubMed ID: 9155831
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the histamine-induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy?
Devillier P; Bousquet J
Clin Exp Allergy; 2007 Mar; 37(3):400-14. PubMed ID: 17359390
[TBL] [Abstract][Full Text] [Related]
16. Loratadine in the treatment of urticaria.
Monroe EW
Clin Ther; 1997; 19(2):232-42. PubMed ID: 9152563
[TBL] [Abstract][Full Text] [Related]
17. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging.
Clough GF; Bennett AR; Church MK
Br J Dermatol; 1998 May; 138(5):806-14. PubMed ID: 9666826
[TBL] [Abstract][Full Text] [Related]
18. In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF-acether) in man.
Fadel R; David B; Herpin-Richard N; Borgnon A; Rassemont R; Rihoux JP
J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):314-20. PubMed ID: 1976664
[TBL] [Abstract][Full Text] [Related]
19. Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin.
Fjellner B; Hägermark O
Acta Derm Venereol; 1985; 65(5):409-12. PubMed ID: 2416164
[TBL] [Abstract][Full Text] [Related]
20. Effects of antihistamines, acetylsalicylic acid and prednisone on cutaneous reactions to kallikrein and prostaglandin E1.
Michaëlsson G
Acta Derm Venereol; 1970; 50(1):31-6. PubMed ID: 4191883
[No Abstract] [Full Text] [Related]
[Next] [New Search]
